This page, 101 CMR 801.00: Drug manufacturer negotiations and accountability, is offered by
Regulation

Regulation 101 CMR 801.00: Drug manufacturer negotiations and accountability

Date: 03/06/2020
Organization: Executive Office of Health and Human Services
Regulatory Authority: M.G.L. c. 118E, § 12A
Official Version: Purchase the official version

101 CMR 413.00 governs the payment rates for youth intermediate-term stabilization services, as further described in 101 CMR 413.00, purchased by a governmental unit.

Contact for 101 CMR 801.00: Drug manufacturer negotiations and accountability

Trial Court Law Libraries

Online

Reference librarians online Chat with a law librarian 

Table of Contents

Downloads for 101 CMR 801.00: Drug manufacturer negotiations and accountability

Contact for 101 CMR 801.00: Drug manufacturer negotiations and accountability

Online

Reference librarians online Chat with a law librarian 
Feedback